Red Queen Bio Hires Former Pentagon Biodefense Official Ian Watson

Red Queen Bio PBC, a Boston-based AI biosecurity company, has appointed Ian Watson as Chief Government Affairs Officer. Watson most recently served as Deputy Assistant Secretary of War for Chemical, Biological, Radiological, and Nuclear Defense.
- Red Queen Bio PBC appointed Ian Watson as Chief Government Affairs Officer.
- Watson most recently served as Deputy Assistant Secretary of War for Chemical, Biological, Radiological, and Nuclear Defense.
- He will lead government affairs engagement with federal agencies and national laboratories, including the Department of War, Department of Energy and Department of Health and Human Services.
- Red Queen Bio is headquartered in Boston and is backed by OpenAI, Cerberus Ventures and others.
What Watson will do at Red Queen Bio
According to the company, Watson will lead Red Queen Bio's government affairs strategy and deepen its engagement with stakeholders across the federal government, national laboratories and agencies. The agencies named in the announcement include the Department of War, the Department of Energy and the Department of Health and Human Services.
Red Queen Bio describes itself as an AI biosecurity company building next-generation technologies to help governments and communities respond to emerging biological threats. It says the hire adds "one of the country's most experienced biodefense and biosecurity leaders" to its executive team as it builds a new generation of biological defense capabilities.
Nikolai Eroshenko, co-founder and CEO of Red Queen Bio, said Watson "has spent his career operating at the intersection of frontier biotechnology, national security and public health." Eroshenko added: "The biosecurity landscape is evolving faster than many traditional systems were designed to respond."
A career across defense and health agencies
The company says Watson has decades of experience spanning biodefense, biotechnology policy, pandemic preparedness and chemical, biological, radiological and nuclear defense.
- Department of War: As Deputy Assistant Secretary of War for Chemical, Biological, Radiological, and Nuclear Defense, he oversaw the development of chemical and biological defense capabilities for the Joint Force. He also served as Executive Secretary of the Biodefense Executive Council and led the Department of War's Biosurveillance Program.
- Department of Health and Human Services: He was Deputy Assistant Secretary and Director of the Office of Strategy, Policy, Planning, and Requirements within the Administration for Strategic Preparedness and Response. His responsibilities there included industrial base expansion, supply-chain management and the Defense Production Act program during the COVID-19 response.
- White House: From 2018 to 2020, he was Assistant Director for Biotechnology and Biosecurity at the Office of Science and Technology Policy. He led the National Bioeconomy Initiative with the National Security Council and co-chaired National Science and Technology Council biodefense and biological sciences subcommittees.
- Earlier roles: He held a series of leadership roles at the Defense Threat Reduction Agency, including overseeing international biological threat reduction programs. He began his career in missile defense and arms control, including work on the Army's PAC-3 and MEADS programs.
Watson on the biological threat landscape
Watson said he was drawn to the company by "the ambition of the mission, and the amazing team they have assembled." He argued that the biological threat landscape "has consistently been described for more than a decade as rapidly accelerating," and that there is a case to be made that it has accelerated ahead of the collective ability to detect, understand and respond with the necessary cohesion and timeliness.
In his words, Red Queen Bio is "confronting the problem with the technical depth and urgency of a technology company, while staying focused on the national security realities."
About the company and what the hire signals
Red Queen Bio was founded by Nikolai Eroshenko and Hannu Rajaniemi. The company says it combines advances in biology and artificial intelligence to create faster, more adaptive approaches to biosecurity and preparedness. It is headquartered in Boston and is backed by OpenAI, Cerberus Ventures and others.
The appointment shows where the company is putting its focus. By bringing in a former senior defense and health official to run government affairs, Red Queen Bio is prioritizing its relationships with federal agencies and national laboratories as it expands its work at the intersection of biotechnology, AI and national security. The announcement does not give details of specific contracts, products or partnerships.
PR Newswire: RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER


